Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 2

2(40.0%)

Phase 3

1(20.0%)

Phase 1

1(20.0%)

N/A

1(20.0%)

5Total

Phase 2(2)

Phase 3(1)

Phase 1(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06358586Not ApplicableCompleted

New Paediatric Formulation of Tachipirina®

Role: collaborator

NCT02654860Phase 1Completed

Dose-finding Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia

Role: collaborator

NCT02385097Phase 3Completed

Chloroprocaine 2% vs Ropivacaine 0.75% in Ultrasound-guided Axillary Nerve Block

Role: collaborator

NCT02481505Phase 2Completed

Spinal Anaesthesia With Chloroprocaine HCl 1% for Elective Lower Limb Procedures of Short Duration.

Role: collaborator

NCT03287219Phase 2Completed

Colon Staining Efficacy of Single Oral Doses of Methylene Blue MMX

Role: collaborator

All 5 trials loaded